MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 5221-5230 Newer>
The Motley Fool
November 3, 2008
Brian Orelli
Make Money, Fight Cancer Which prostate cancer fighting companies have promising investment potential? mark for My Articles 482 similar articles
Chemistry World
November 2008
Derek Lowe
Column: In the pipeline Drug discovery chemists live by assay data; we depend on these numbers to tell us if we're heading in the right direction with our molecules. mark for My Articles 70 similar articles
BusinessWeek
October 31, 2008
Arlene Weintraub
Pfizer CEO Kindler Has His Work Cut Out for Him Investors want a fresh perspective for post-Lipitor Pfizer, but they're not yet convinced outsider CEO Jeffrey Kindler is the one to bring it. mark for My Articles 259 similar articles
Chemistry World
October 31, 2008
Matt Wilkinson
GSK Snaps up Hepatitis Drug Developer In a bid to strengthen its efforts to develop new hepatitis therapies, GSK has agreed to buy Genelabs Technologies in a deal worth $57 million. mark for My Articles 162 similar articles
The Motley Fool
October 31, 2008
Brian Orelli
From Precious to Precocious Natus Medical may make some acquisitions to continue boosting its revenue. mark for My Articles 40 similar articles
The Motley Fool
October 31, 2008
Brian Orelli
Disease Is Good for Novo Nordisk The Danish drugmaker is able to grow despite the Danish krone moving against the currencies that predominate its sales.. mark for My Articles 253 similar articles
The Motley Fool
October 31, 2008
Brian Orelli
A Generic McMansion Mylan took an awfully big bite when it purchased Merck KGaA's generic-drug business last year, but so far it's proven that it can handle it. mark for My Articles 213 similar articles
The Motley Fool
October 31, 2008
Brian Orelli
World's Scariest Stock: Dendreon The fear of the unknown makes investing scary, and things don't get much more unknown than the future of biotech company Dendreon. mark for My Articles 228 similar articles
BusinessWeek
October 30, 2008
Four New Pharmaceutical Chief Executives Speak Out The CEOs of Pfizer, Roche, Eli Lilly, and Bristol-Myers Squibb address topics from dealmaking to the pharmaceutical industry's image problems. mark for My Articles 180 similar articles
The Motley Fool
October 30, 2008
Anders Bylund
A Focus Too Broad Is No Focus at All JDS Uniphase needs to shape up and play to its strengths. mark for My Articles 93 similar articles
<Older 5221-5230 Newer>    Return to current articles.